| (S)-nicotine | decreases expression | ISO | RGD:2836 | 6480464 | Nicotine results in decreased expression of HSD17B1 protein | CTD | PMID:20498001 |
| (S)-nicotine | multiple interactions | ISO | RGD:2836 | 6480464 | Taurine inhibits the reaction [Nicotine results in decreased expression of HSD17B1 protein] | CTD | PMID:20498001 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:2836 | 6480464 | Ethinyl Estradiol results in decreased expression of HSD17B1 mRNA | CTD | PMID:12655037 |
| 17beta-estradiol | increases expression | ISO | RGD:736216 | 6480464 | Estradiol results in increased expression of HSD17B1 mRNA | CTD | PMID:12858341 |
| 17beta-estradiol | affects metabolic processing | ISO | RGD:736216 | 6480464 | HSD17B1 protein affects the metabolism of Estradiol | CTD | PMID:16054388 |
| 17beta-estradiol | increases chemical synthesis | ISO | RGD:736216 | 6480464 | HSD17B1 protein results in increased chemical synthesis of Estradiol | CTD | PMID:16054388 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:2836 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HSD17B1 mRNA | CTD | PMID:19276399 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HSD17B1 mRNA | CTD | PMID:22889882 |
| 2,6-dibromophenol | decreases expression | ISO | RGD:736216 | 6480464 | 2,6-dibromophenol results in decreased expression of HSD17B1 mRNA | CTD | PMID:17447562 |
| 4,4'-diaminodiphenylmethane | decreases expression | EXP | | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of HSD17B1 mRNA | CTD | PMID:18648102 |
| 8-bromo-3',5'-cyclic AMP | multiple interactions | ISO | RGD:736216 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate promotes the reaction [bisphenol A results in decreased expression of HSD17B1 mRNA] | CTD | PMID:21273127 |
| 9-cis-retinoic acid | increases activity | ISO | RGD:736216 | 6480464 | alitretinoin results in increased activity of HSD17B1 protein | CTD | PMID:16513093 |
| 9-cis-retinoic acid | increases expression | ISO | RGD:736216 | 6480464 | alitretinoin results in increased expression of HSD17B1 mRNA | CTD | PMID:16513093 |
| acetaldehyde | multiple interactions | EXP | | 6480464 | [CGA protein results in increased abundance of Acetaldehyde] which results in increased expression of HSD17B1 mRNA | CTD | PMID:22285649 |
| all-trans-retinoic acid | increases expression | ISO | RGD:736216 | 6480464 | Tretinoin results in increased expression of HSD17B1 mRNA | CTD | PMID:16513093 PMID:16249480 |
| all-trans-retinoic acid | increases expression | ISO | RGD:736216 | 6480464 | Tretinoin results in increased expression of HSD17B1 mRNA | CTD | PMID:16249480 PMID:16513093 |
| all-trans-retinoic acid | increases activity | ISO | RGD:736216 | 6480464 | Tretinoin results in increased activity of HSD17B1 protein | CTD | PMID:16513093 PMID:11245337 |
| all-trans-retinoic acid | increases activity | ISO | RGD:736216 | 6480464 | Tretinoin results in increased activity of HSD17B1 protein | CTD | PMID:11245337 PMID:16513093 |
| ammonium chloride | affects expression | ISO | RGD:2836 | 6480464 | Ammonium Chloride affects the expression of HSD17B1 mRNA | CTD | PMID:16483693 |
| androst-5-ene-3beta,17beta-diol | affects metabolic processing | ISO | RGD:736216 | 6480464 | HSD17B1 protein affects the metabolism of Androstenediol | CTD | PMID:16054388 |
| androst-5-ene-3beta,17beta-diol | increases chemical synthesis | ISO | RGD:736216 | 6480464 | HSD17B1 protein results in increased chemical synthesis of Androstenediol | CTD | PMID:16054388 |
| Aroclor 1254 | decreases activity | ISO | RGD:2836 | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased activity of HSD17B1 protein | CTD | PMID:15808795 PMID:17283232 |
| Aroclor 1254 | decreases activity | ISO | RGD:2836 | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased activity of HSD17B1 protein | CTD | PMID:17283232 PMID:15808795 |
| Aroclor 1254 | decreases expression | ISO | RGD:2836 | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of HSD17B1 mRNA | CTD | PMID:17283232 |
| bisphenol A | multiple interactions | ISO | RGD:736216 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate promotes the reaction [bisphenol A results in decreased expression of HSD17B1 mRNA] | CTD | PMID:21273127 |
| bisphenol A | decreases expression | ISO | RGD:736216 | 6480464 | bisphenol A results in decreased expression of HSD17B1 mRNA | CTD | PMID:21273127 |
| coumarin | multiple interactions | ISO | RGD:736216 | 6480464 | coumarin analog inhibits the reaction [[HSD17B1 protein co-treated with NADP] results in increased reduction of Estrone] | CTD | PMID:21232530 |
| cyhexatin | increases activity | ISO | RGD:736216 | 6480464 | cyhexatin results in increased activity of HSD17B1 protein | CTD | PMID:16513093 |
| cyhexatin | increases expression | ISO | RGD:736216 | 6480464 | cyhexatin results in increased expression of HSD17B1 mRNA | CTD | PMID:16513093 |
| DDT | decreases expression | ISO | RGD:736216 | 6480464 | DDT results in decreased expression of HSD17B1 mRNA | CTD | PMID:12858341 |
| DDT | multiple interactions | ISO | RGD:736216 | 6480464 | MT2A protein inhibits the reaction [DDT results in decreased expression of HSD17B1 mRNA] | CTD | PMID:12858341 |
| dehydroepiandrosterone | affects metabolic processing | ISO | RGD:736216 | 6480464 | HSD17B1 protein affects the metabolism of Dehydroepiandrosterone | CTD | PMID:16054388 |
| dehydroepiandrosterone | increases chemical synthesis | ISO | RGD:736216 | 6480464 | HSD17B1 protein results in increased chemical synthesis of Dehydroepiandrosterone | CTD | PMID:16054388 |
| dexamethasone | affects expression | ISO | RGD:2836 | 6480464 | Dexamethasone affects the expression of HSD17B1 mRNA | CTD | PMID:15102944 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of HSD17B1 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of HSD17B1 mRNA | CTD | PMID:17361019 PMID:21266533 |
| diethylstilbestrol | decreases expression | ISO | RGD:736216 | 6480464 | Diethylstilbestrol results in decreased expression of HSD17B1 mRNA | CTD | PMID:12858341 |
| estrone | affects metabolic processing | ISO | RGD:736216 | 6480464 | HSD17B1 protein affects the metabolism of Estrone | CTD | PMID:16054388 |
| estrone | multiple interactions | ISO | RGD:736216 | 6480464 | coumarin analog inhibits the reaction [[HSD17B1 protein co-treated with NADP] results in increased reduction of Estrone] | CTD | PMID:21232530 |
| estrone | increases chemical synthesis | ISO | RGD:736216 | 6480464 | HSD17B1 protein results in increased chemical synthesis of Estrone | CTD | PMID:16054388 |
| fenvalerate | decreases expression | ISO | RGD:2836 | 6480464 | fenvalerate results in decreased expression of HSD17B1 mRNA | CTD | PMID:16001830 |
| fenvalerate | affects expression | EXP | | 6480464 | fenvalerate affects the expression of HSD17B1 protein | CTD | PMID:21232584 |
| formaldehyde | decreases expression | ISO | RGD:736216 | 6480464 | Formaldehyde results in decreased expression of HSD17B1 mRNA | CTD | PMID:20655997 |
| gamma-hexachlorocyclohexane | decreases activity | ISO | RGD:2836 | 6480464 | Lindane results in decreased activity of HSD17B1 protein | CTD | PMID:11404799 |
| genistein | decreases activity | ISO | RGD:736216 | 6480464 | Genistein results in decreased activity of HSD17B1 protein | CTD | PMID:15876411 |
| glutathione | multiple interactions | ISO | RGD:2836 | 6480464 | Glutathione inhibits the reaction [sodium arsenite results in decreased activity of HSD17B1 protein] | CTD | PMID:20580664 |
| methoxychlor | decreases expression | ISO | RGD:736216 | 6480464 | Methoxychlor results in decreased expression of HSD17B1 mRNA | CTD | PMID:12858341 |
| methoxychlor | decreases expression | EXP | | 6480464 | Methoxychlor results in decreased expression of HSD17B1 mRNA | CTD | PMID:21514315 |
| methoxychlor | increases expression | ISO | RGD:2836 | 6480464 | Methoxychlor results in increased expression of HSD17B1 mRNA | CTD | PMID:22285353 |
| methoxychlor | multiple interactions | ISO | RGD:736216 | 6480464 | MT2A protein inhibits the reaction [Methoxychlor results in decreased expression of HSD17B1 mRNA] | CTD | PMID:12858341 |
| NADP zwitterion | multiple interactions | ISO | RGD:736216 | 6480464 | coumarin analog inhibits the reaction [[HSD17B1 protein co-treated with NADP] results in increased reduction of Estrone] | CTD | PMID:21232530 |
| NADP(+) | multiple interactions | ISO | RGD:736216 | 6480464 | coumarin analog inhibits the reaction [[HSD17B1 protein co-treated with NADP] results in increased reduction of Estrone] | CTD | PMID:21232530 |
| ochratoxin A | decreases expression | ISO | RGD:2836 | 6480464 | ochratoxin A results in decreased expression of HSD17B1 mRNA | CTD | PMID:18417182 |
| perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of HSD17B1 mRNA | CTD | PMID:20118188 |
| perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | PPARA gene mutant form inhibits the reaction [perfluorooctanoic acid results in decreased expression of HSD17B1 protein] | CTD | PMID:22414604 |
| perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of HSD17B1 protein | CTD | PMID:22414604 |
| perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of HSD17B1 protein | CTD | PMID:20118188 |
| perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | PPARA promotes the reaction [perfluorooctanoic acid results in increased expression of HSD17B1 mRNA] | CTD | PMID:20118188 |
| pregnenolone | increases expression | EXP | | 6480464 | Pregnenolone results in increased expression of HSD17B1 mRNA | CTD | PMID:20956811 |
| taurine | multiple interactions | ISO | RGD:2836 | 6480464 | Taurine inhibits the reaction [Nicotine results in decreased expression of HSD17B1 protein] | CTD | PMID:20498001 |
| testosterone | affects chemical synthesis | EXP | | 6480464 | HSD17B1 protein affects the chemical synthesis of Testosterone | CTD | PMID:15932923 |
| tetracycline | increases expression | EXP | | 6480464 | Tetracycline results in increased expression of HSD17B1 mRNA | CTD | PMID:16917069 |
| tributylstannane | increases activity | ISO | RGD:736216 | 6480464 | tributyltin results in increased activity of HSD17B1 protein | CTD | PMID:16513093 |
| tributylstannane | increases expression | ISO | RGD:736216 | 6480464 | tributyltin results in increased expression of HSD17B1 mRNA | CTD | PMID:16513093 |
| triphenylstannanol | increases activity | ISO | RGD:736216 | 6480464 | triphenyltin hydroxide results in increased activity of HSD17B1 protein | CTD | PMID:16513093 |
| triphenylstannanol | increases expression | ISO | RGD:736216 | 6480464 | triphenyltin hydroxide results in increased expression of HSD17B1 mRNA | CTD | PMID:16513093 |
| valproic acid | decreases expression | ISO | RGD:736216 | 6480464 | Valproic Acid results in decreased expression of HSD17B1 mRNA | CTD | PMID:19566492 |